These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. New naphthyridinomycin-type antibiotics, aclidinomycins A and B, from Streptomyces halstedi. Cang S; Ohta S; Chiba H; Johdo O; Nomura H; Nagamatsu Y; Yoshimoto A J Antibiot (Tokyo); 2001 Mar; 54(3):304-7. PubMed ID: 11372787 [No Abstract] [Full Text] [Related]
43. A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity. Pavlov AY; Lazhko EI; Preobrazhenskaya MN J Antibiot (Tokyo); 1997 Jun; 50(6):509-13. PubMed ID: 9268008 [TBL] [Abstract][Full Text] [Related]
44. Izupeptins A and B, new glycopeptide antibiotics produced by an actinomycete. Spiri-Nakagawa P; Fukushi Y; Maebashi K; Imamura N; Takahashi Y; Tanaka Y; Tanaka H; Omura S J Antibiot (Tokyo); 1986 Dec; 39(12):1719-23. PubMed ID: 3818445 [TBL] [Abstract][Full Text] [Related]
45. New insights into rifamycin B biosynthesis: isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways. Stratmann A; Schupp T; Toupet C; Schilling W; Oberer L; Traber R J Antibiot (Tokyo); 2002 Apr; 55(4):396-406. PubMed ID: 12061548 [TBL] [Abstract][Full Text] [Related]
46. 167-A, a new antibiotic produced by a mutant of an inactive wild strain of Amycolata autotrophica. Malkina ND; Dudnik YV; Lysenkova LN; Lazhko EI; Galatenko OA; Katrukha GS J Antibiot (Tokyo); 1994 Mar; 47(3):342-8. PubMed ID: 8175487 [TBL] [Abstract][Full Text] [Related]
47. New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. II. Isolation and structure elucidation. Kimura K; Ikeda Y; Kagami S; Yoshihama M; Ubukata M; Esumi Y; Osada H; Isono K J Antibiot (Tokyo); 1998 Jul; 51(7):647-54. PubMed ID: 9727391 [TBL] [Abstract][Full Text] [Related]
48. Screening for non-polyenic antifungal antibiotics produced by rare Actinomycetales. Hacène H; Sabaou N; Bounaga N; Lefebvre G Microbios; 1994; 79(319):81-5. PubMed ID: 7968663 [TBL] [Abstract][Full Text] [Related]
50. [The structure of eremomycin, a new antibiotic of the group of polycyclic glycopeptides]. Lomakina NN; Berdnikova TF; Tokareva NL; Abramova EA; Dokshina NIu Antibiot Khimioter; 1989 Apr; 34(4):254-8. PubMed ID: 2751381 [TBL] [Abstract][Full Text] [Related]
51. Extraction and Analysis of Peptidoglycan Cell Wall Precursors. Binda E; Carrano L; Marcone GL; Marinelli F Methods Mol Biol; 2016; 1440():153-70. PubMed ID: 27311671 [TBL] [Abstract][Full Text] [Related]
52. [Study of the activity of a new glycopeptide antibiotic eremomycin combined with tobramycin against Staphylococci in vitro]. Iakushkina IV; Malkova IV; Prozorova IN Antibiot Khimioter; 1988 May; 33(5):342-5. PubMed ID: 3415389 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal. Pavlov AY; Berdnikova TF; Olsufyeva EN; Lazhko EI; Malkova IV; Preobrazhenskaya MN; Testa RT; Petersen PJ J Antibiot (Tokyo); 1993 Nov; 46(11):1731-9. PubMed ID: 8270496 [TBL] [Abstract][Full Text] [Related]
54. Antibacterial and antilarval compounds from marine gorgonian-associated bacterium Bacillus amyloliquefaciens SCSIO 00856. Gao CH; Tian XP; Qi SH; Luo XM; Wang P; Zhang S J Antibiot (Tokyo); 2010 Apr; 63(4):191-3. PubMed ID: 20150929 [No Abstract] [Full Text] [Related]
55. Aridicins, novel glycopeptide antibiotics. II. Isolation and characterization. Sitrin RD; Chan GW; Dingerdissen JJ; Holl W; Hoover JR; Valenta JR; Webb L; Snader KM J Antibiot (Tokyo); 1985 May; 38(5):561-71. PubMed ID: 4019308 [TBL] [Abstract][Full Text] [Related]
56. Chemical modification of the eremomycin antibiotic. Formation of a cyclic covalent dimer. Sztaricskai F; Batta G; Dinya Z; Miroshnikova OV; Preobrazhenskaya MN; Hernádi F; Koncz A; Boda Z J Antibiot (Tokyo); 2001 Mar; 54(3):314-9. PubMed ID: 11372789 [No Abstract] [Full Text] [Related]
57. Tetrazomine, a new antibiotic produced by an actinomycete strain. Taxonomy, fermentation, isolation and characterization. Suzuki K; Sato T; Morioka M; Nagai K; Abe K; Yamaguchi H; Saito T; Ohmi Y; Susaki K J Antibiot (Tokyo); 1991 May; 44(5):479-85. PubMed ID: 2061191 [TBL] [Abstract][Full Text] [Related]
58. Isolation and structure determination of a novel complex of the teicoplanin family. Quarta C; Borghi A; Zerilli LF; De Pietro MT; Ferrari P; Trani A; Lancini GC J Antibiot (Tokyo); 1996 Jul; 49(7):644-50. PubMed ID: 8784424 [TBL] [Abstract][Full Text] [Related]
59. Isolation and structural elucidation of AC326-alpha, a new member of the moenomycin group. He H; Shen B; Korshalla J; Siegel MM; Carter GT J Antibiot (Tokyo); 2000 Feb; 53(2):191-5. PubMed ID: 10805581 [No Abstract] [Full Text] [Related]
60. Antibacterial activity and genotypic-phenotypic characteristics of bacteriocin-producing Bacillus subtilis KKU213: potential as a probiotic strain. Khochamit N; Siripornadulsil S; Sukon P; Siripornadulsil W Microbiol Res; 2015 Jan; 170():36-50. PubMed ID: 25440998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]